SGLT2 Inhibitors for Type 2 Diabetes Mellitus Treatment

Authors
Publication date
1 January 2015
Publisher
Touro Scholar

Abstract

SGLT2 inhibitors are plausible second-line drugs that provide powerful additional A1c-lowering effects while inducing weight loss without hypoglycemia

    Similar works

    Full text

    thumbnail-image

    Available Versions

    The Touro College and University System

    redirect
    oaioai:touroscholar.touro.edu:tun...
    Last time updated on 09/07/2019